发明公开
- 专利标题： MINERALOCORTICOID RECEPTOR ANTAGONIST AND METHODS OF USE
- 专利标题（中）： MINOROCORTICOID受体拮抗剂及其使用方法
-
申请号： EP10707770.3申请日： 2010-03-04
-
公开(公告)号： EP2406252A1公开(公告)日： 2012-01-18
- 发明人: COATES, David, Andrew , GAVARDINAS, Konstantinos , JADHAV, Prabhakar, Kondaji
- 申请人： Eli Lilly and Company
- 申请人地址： Lilly Corporate Center Indianapolis, IN 46285 US
- 专利权人： Eli Lilly and Company
- 当前专利权人： Eli Lilly and Company
- 当前专利权人地址： Lilly Corporate Center Indianapolis, IN 46285 US
- 代理机构： Bassinder, Emma Marie
- 优先权： US159578P 20090312
- 国际公布： WO2010104721 20100916
- 主分类号： C07D405/06
- IPC分类号： C07D405/06 ; C07D405/14 ; C07D498/04 ; A61K31/4184 ; A61K31/5383 ; A61P13/12 ; A61P3/10 ; A61P5/40
摘要：
The present invention provides a compound of the formula: Compound (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising Compound (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering Compound (I), or a pharmaceutically acceptable salt thereof.
公开/授权文献
- EP2406252B1 MINERALOCORTICOID RECEPTOR ANTAGONIST AND METHODS OF USE 公开/授权日：2015-05-20
信息查询
